Roche Diagnostics CONFIRM CD79a RabbitMono

Roche Diagnostics Corporation CONFIRM CD79a RabbitMono; Ventana Medical Systems, Inc. (Ventana) CONFIRM anti-CD79a (SP18) Rabbit Monoclonal Primary Antibody is intended for the detection of CD79a in normal and neoplastic human tissues. Anti- CD79a is directed against a protein expressed on the surface of B lymphocytes at all stages of maturation, from B lymphocyte precursors through plasma cells. Expression of CD79a may aid in the identification of B cell lineage in malignant lymphomas. The antibody is intended for qualitative staining in sections of formalin fixed, paraffin embedded tissue. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information and proper controls. This antibody is intended for in vitro diagnostic (IVD) use. 50 Tests - ROCHGSK (Additional S&H or Hazmat Fees May Apply)